Cargando…

Spatial organization of heterogeneous immunotherapy target antigen expression in high-grade glioma

High-grade (WHO grades III-IV) glioma remains one of the most lethal human cancers. Adoptive transfer of tumor-targeting chimeric antigen receptor (CAR)-redirected T cells for high-grade glioma has revealed promising indications of anti-tumor activity, but objective clinical responses remain elusive...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barish, Michael E., Weng, Lihong, Awabdeh, Dina, Zhai, Yubo, Starr, Renate, D'Apuzzo, Massimo, Rockne, Russell C., Li, Haiqing, Badie, Behnam, Forman, Stephen J., Brown, Christine E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2022
Materias:	Original article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108993/ https://www.ncbi.nlm.nih.gov/pubmed/35550513 http://dx.doi.org/10.1016/j.neo.2022.100801

Ejemplares similares

Early Changes in Tumor Perfusion from T1-Weighted Dynamic Contrast-Enhanced MRI following Neural Stem Cell-Mediated Therapy of Recurrent High-Grade Glioma Correlate with Overall Survival
por: Sahoo, Prativa, et al.
Publicado: (2018)

Adoptive transfer of IL13Rα2-specific T cells for the treatment of glioblastoma: building on clinical achievements with second-generation CARs
por: Brown, Christine E, et al.
Publicado: (2013)

Glioma IL13Rα2 Is Associated with Mesenchymal Signature Gene Expression and Poor Patient Prognosis
por: Brown, Christine E., et al.
Publicado: (2013)

Pituitary metastasis: a rare condition
por: Javanbakht, Aida, et al.
Publicado: (2018)

Clinical development of IL13Rα2-targeting CAR T cells for the treatment of glioblastoma
por: Brown, Christine E, et al.
Publicado: (2015)

Characterization of Arginase Expression in Glioma-Associated Microglia and Macrophages
por: Zhang, Ian, et al.
Publicado: (2016)

Feasibility of intracerebrally administering multiple doses of genetically modified neural stem cells to locally produce chemotherapy in glioma patients
por: Portnow, Jana, et al.
Publicado: (2021)

Cytokine Induction of VCAM-1 but Not IL13Rα2 on Glioma Cells: A Tale of Two Antibodies
por: Mahadev, Vaidehi, et al.
Publicado: (2014)

Systemic Anti–PD-1 Immunotherapy Results in PD-1 Blockade on T Cells in the Cerebrospinal Fluid
por: Portnow, Jana, et al.
Publicado: (2020)

TLR9 signaling through NF-κB/RELA and STAT3 promotes tumor-propagating potential of prostate cancer cells
por: Moreira, Dayson, et al.
Publicado: (2015)

Immunotherapy and radiation for high-grade glioma: a narrative review
por: Fakhoury, Kareem R., et al.
Publicado: (2021)

Microglia and Macrophages in Malignant Gliomas: Recent Discoveries and Implications for Promising Therapies
por: Carvalho da Fonseca, Anna Carolina, et al.
Publicado: (2013)

Metronomic Doses of Temozolomide Enhance the Efficacy of Carbon Nanotube CpG Immunotherapy in an Invasive Glioma Model
por: Ouyang, Mao, et al.
Publicado: (2016)

Characterizing temporal genomic heterogeneity in pediatric low-grade gliomas
por: Lazow, Margot A., et al.
Publicado: (2020)

Subtype and grade-dependent spatial heterogeneity of T-cell infiltration in pediatric glioma
por: Robinson, M Hope, et al.
Publicado: (2020)

New Approach Based on Compressive Sampling for Sample Rate Enhancement in DASs for Low-Cost Sensing Nodes
por: Bonavolontà, Francesco, et al.
Publicado: (2014)

Next Generation CAR T Cells for the Immunotherapy of High-Grade Glioma
por: Petersen, Christopher T., et al.
Publicado: (2019)

Immunotherapy Approaches in Isocitrate-Dehydrogenase-Mutant Low-Grade Glioma
por: Gallus, Marco, et al.
Publicado: (2023)

Characterizing temporal genomic heterogeneity in pediatric high-grade gliomas
por: Salloum, Ralph, et al.
Publicado: (2017)

Development of immunotherapy for high-grade gliomas: Overcoming the immunosuppressive tumor microenvironment
por: Franson, Andrea, et al.
Publicado: (2022)

Heterogeneous Expression of Proangiogenic and Coagulation Proteins in Gliomas of Different Histopathological Grade
por: Wojtukiewicz, Marek Z., et al.
Publicado: (2021)

Dissection of transcriptomic and epigenetic heterogeneity of grade 4 gliomas: implications for prognosis
por: Zeng, Chang, et al.
Publicado: (2023)

Micro-Raman Spectroscopy for Monitoring Changes in Periodontal Ligaments and Gingival Crevicular Fluid
por: Camerlingo, Carlo, et al.
Publicado: (2014)

Patient-derived xenografts of different grade gliomas retain the heterogeneous histological and genetic features of human gliomas
por: Zeng, Wenxin, et al.
Publicado: (2020)

Comprehensive Characterization of Pyroptosis Patterns with Implications in Prognosis and Immunotherapy in Low-Grade Gliomas
por: Zhou, Zijian, et al.
Publicado: (2022)

Uncovering the Immune Cell Infiltration Landscape in Low-Grade Glioma for Aiding Immunotherapy
por: Yang, Youyuan, et al.
Publicado: (2022)

Recurrence- and Malignant Progression-Associated Biomarkers in Low-Grade Gliomas and Their Roles in Immunotherapy
por: Teng, Chubei, et al.
Publicado: (2022)

Identification of cuproptosis‐related lncRNAs for prognosis and immunotherapy in glioma
por: Wang, Lin, et al.
Publicado: (2022)

Spatial immune heterogeneity of hypoxia-induced exhausted features in high-grade glioma
por: Kim, A-Reum, et al.
Publicado: (2022)

Comparison between rapid and mixed maxillary expansion through an assessment of arch changes on dental casts
por: Grassia, Vincenzo, et al.
Publicado: (2015)

Dentoskeletal effects of early class III treatment protocol based on timing of intervention in children
por: Nucci, Ludovica, et al.
Publicado: (2021)

Hospital Volume as a Source of Variation for Major Complications and Early In-Hospital Mortality After Total Joint Arthroplasty
por: D’Apuzzo, Michele R., et al.
Publicado: (2022)

μ-FTIR, μ-Raman, and SERS Analysis of Amide I Spectral Region in Oral Biofluid Samples during Orthodontic Treatment †
por: Camerlingo, Carlo, et al.
Publicado: (2022)

Predictability of crowding resolution in clear aligner treatment
por: Fiori, Adriana, et al.
Publicado: (2022)

Immunotherapy for malignant glioma
por: Suryadevara, Carter M., et al.
Publicado: (2015)

Chemotherapy for high-grade gliomas
por: Galanis, E, et al.
Publicado: (2000)

Clinical decision making in the era of immunotherapy for high grade-glioma: report of four cases
por: Ranjan, Surabhi, et al.
Publicado: (2018)

Advances in radiotherapy and comprehensive treatment of high-grade glioma: immunotherapy and tumor-treating fields
por: Liu, Shiyu, et al.
Publicado: (2021)

T-Cell Immunotherapy for Pediatric High-Grade Gliomas: New Insights to Overcoming Therapeutic Challenges
por: Haydar, Dalia, et al.
Publicado: (2021)

Heme Oxygenase-1 Predicts Risk Stratification and Immunotherapy Efficacy in Lower Grade Gliomas
por: Ye, Wenrui, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lo9pldvgdaricpa5dsc4sk0fmi